Prescribing information: difference between revisions
Diff·revision 11 → 12·16:40, 20 Mar 2025
Difference between revision 11 and revision 12 of Prescribing information. 2 lines changed; the page grew by 225 bytes.
| Revision 11 — 15:49, 24 Feb 2025 DEXA_Dilys (talk) expand §Structure 3,458 bytes ±0 | Revision 12 — 16:40, 20 Mar 2025 ArchiveBot (talk) bot: sort category members 3,683 bytes +225 | ||
|---|---|---|---|
| 32 | The last row is the one relevant to much of this wiki. Material sold for research has no approved labelling, so there is no prescribing information for it, and clinical information about an approved product is not about it.{{r|usp1503}} | 32 | The last row is the one relevant to much of this wiki. Material sold for research has no approved labelling, so there is no prescribing information for it, and clinical information about an approved product is not about it.{{r|usp1503}} |
| 33 | 33 | ||
| + | 34 | Labelling also lags. A finding published after the most recent labelling revision will not appear, which is why the label is authoritative for regulatory status and not for the current state of the literature.{{r|ema_smpc}} | |
| + | 35 | ||
| 34 | == References == | 36 | == References == |
| 35 | {{reflist}} | 37 | {{reflist}} |